scholarly journals Parkinson’s Disease and Home Healthcare Use and Expenditures among Elderly Medicare Beneficiaries

2015 ◽  
Vol 2015 ◽  
pp. 1-11
Author(s):  
Sandipan Bhattacharjee ◽  
Aaron Metzger ◽  
Cindy Tworek ◽  
Wenhui Wei ◽  
Xiaoyun Pan ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Ordinary Least Squares ◽  
Home Health ◽  
Home Healthcare ◽  
Medicare Beneficiaries ◽  
Healthcare Use ◽  
Individual Level ◽  
Cohort Study Design ◽  
Observational Cohort

This study estimated excess home healthcare use and expenditures among elderly Medicare beneficiaries (age ≥ 65 years) with Parkinson’s disease (PD) compared to those without PD and analyzed the extent to which predisposing, enabling, need factors, personal health choice, and external environment contribute to the excess home healthcare use and expenditures among individuals with PD. A retrospective, observational, cohort study design using Medicare 5% sample claims for years 2006-2007 was used for this study. Logistic regressions and Ordinary Least Squares regressions were used to assess the association of PD with home health use and expenditures, respectively. Postregression nonlinear and linear decomposition techniques were used to understand the extent to which differences in home healthcare use and expenditures among elderly Medicare beneficiaries with and without PD can be explained by individual-level factors. Elderly Medicare beneficiaries with PD had higher home health use and expenditures compared to those without PD. 27.5% and 18% of the gap in home health use and expenditures, respectively, were explained by differences in characteristics between the PD and no PD groups. A large portion of the differences in home healthcare use and expenditures remained unexplained.

Direct costs and survival of medicare beneficiaries with early and advanced parkinson’s disease

2012 ◽  
Vol 18 (4) ◽  
pp. 321-326 ◽  
Author(s):  
A. Kaltenboeck ◽  
S.J. Johnson ◽  
M.R. Davis ◽  
H.G. Birnbaum ◽  
C.A. Carroll ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Direct Costs ◽  
Medicare Beneficiaries ◽  
Advanced Parkinson’S Disease

scholarly journals Perspectives on Care for Late-Stage Parkinson’s Disease

2021 ◽  
Vol 2021 ◽  
pp. 1-11
Author(s):  
Kristina Rosqvist ◽  
Marianne Kylberg ◽  
Charlotte Löfqvist ◽  
Anette Schrag ◽  
Per Odin ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Health Care ◽  
Parkinson's Disease ◽  
Everyday Life ◽  
Residential Care ◽  
Home Health Care ◽  
Late Stage ◽  
Informal Caregivers ◽  
Home Health ◽  
Main Category

In the late stage of Parkinson’s disease (PD), there is an increasing disease burden not only for the patients but also for their informal caregivers and the health and social services systems. The aim of this study was to explore experiences of late-stage PD patients’ and their informal caregivers’ satisfaction with care and support, in order to better understand how they perceive the treatment and care they receive. This qualitative substudy was part of the longitudinal European multicentre Care of Late Stage Parkinsonism (CLaSP) project. Individual semistructured interviews were conducted with patients (n = 11) and informal caregivers (n = 9) in Sweden. Data were analysed through the content analysis technique. The final analyses generated one main category: “We are trying to get by both with and without the formal care” and five subcategories: “Availability of health care is important for managing symptoms and everyday life”; “Dependence on others and scheduled days form everyday life”; “There is a wish to get adequate help when it is needed”; “Mixed feelings on future housing and respite care”; and “Family responsibility and loyalty for a functioning everyday life”. Having regular contact with PD-specialised health care was perceived as important. Greater access to physiotherapy was wished for. Maintaining autonomy was perceived as important by patients, in both home health care and a future residential care setting. Responsibility and loyalty between spouses and support from children enabled everyday life to carry on at home, indicating a vulnerability for those without an informal caregiver. The results suggest that regular access to PD-specialised health care is important and that a specialised and multidisciplinary approach to the management of PD symptomatology is likely necessary. Non-PD-specialised staff in home health care and residential care facilities should regularly be given opportunities to obtain PD-specific education and information.

scholarly journals Differences in Home Health Nursing Care for Patients with Parkinson’s Disease by Stage of Progress: Patients in Hoehn and Yahr Stages III, IV, and V

2021 ◽  
Vol 2021 ◽  
pp. 1-10
Author(s):  
Yumi Iwasa ◽  
Izumi Saito ◽  
Miyoko Suzuki
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Nursing Homes ◽  
Nursing Care ◽  
Clinical Care ◽  
Stage Iv ◽  
Home Health ◽  
Stage Iii ◽  
Home Health Nursing ◽  
Health Nursing

As societal aging progresses globally, the number of people with Parkinson’s disease (PD) is expected to increase worldwide. Accordingly, the need for home health nursing care for homebound patients with PD will continue to expand. We aimed to clarify the clinical care provided by nurses to homebound patients in each Hoehn and Yahr (HY) stage of the disease. We analyzed the visiting nursing records of patients and observed the clinical care provided by nurses in patients’ homes and nursing homes to compare the attributes of patients and differences in nursing care by HY stage. All 21 patients surveyed were at or above HY stage III. The nurses visited each patient nine times per month, on average. The number of visits was positively correlated with HY stage. All stage III patients were homebound, and medication dosage and dispensation assistance were quite common. Several stage IV patients were admitted into nursing homes. In stage V, assistance with hygiene, bedsore management, urine withdrawal/bladder catheters, and other excretory aids were among the most common forms of nursing care provided. As patients’ stages progressed, guidance/educational care meant to encourage self-care decreased and direct physical care increased. Clear differences in nursing care were observed between HY stages, suggesting that stage-based protocols regarding the nature and frequency of nursing visits may be useful for ensuring consistent, effective care of patients with PD.

scholarly journals Prevalence and incidence of Parkinson’s disease and drug-induced parkinsonism in Korea

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Sola Han ◽  
Siin Kim ◽  
Hyungtae Kim ◽  
Hae-Won Shin ◽  
Kyoung-Sae Na ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Study Design ◽  
Cross Sectional Study ◽  
Drug Induced ◽  
Cross Sectional ◽  
Cohort Study Design ◽  
Icd 10 ◽  
Incident Cases ◽  
Antiparkinsonian Drugs

Abstract Background Parkinson’s disease (PD) and drug-induced parkinsonism (DIP) are the major diseases of parkinsonism. To better understand parkinsonism, we aimed to assess the prevalence and incidence of PD and DIP in Korea from 2012 to 2015. Methods We used the Health Insurance Review and Assessment Service database, which covers the entire population in Korea. We used claims during 2011–2015 to assess epidemiology of PD and DIP during 2012–2015. Retrospective cross-sectional study design was employed to assess prevalence, whereas retrospective cohort study design was used to determine incidence. Patients with at least one claim with ICD-10 G20 and who received antiparkinsonian drugs for at least 60 days were classified as having PD. We excluded patients with antiparkinsonian drugs that can be used for indications other than PD. Patients with at least one claim with ICD-10 G211 or G251 during the prescription period of drugs that are frequently related with DIP were classified as having DIP. Incident cases had a disease-free period of 1 year before diagnosis. To evaluate the significance of changes in the prevalence or incidence over time, Poisson regression was used to determine p for trend. Results The prevalence of PD increased from 156.9 per 100,000 persons in 2012 to 181.3 per 100,000 persons in 2015 (p for trend< 0.0001). The incidence of PD decreased steadily from 35.4 per 100,000 person-years in 2012 to 33.3 per 100,000 person-years in 2015 (p for trend< 0.0001). The prevalence of DIP increased from 7.3 per 100,000 persons in 2012 to 15.4 per 100,000 persons in 2015 (p for trend< 0.0001) and the incidence of DIP increased from 7.1 per 100,000 person-years in 2012 to 13.9 per 100,000 person-years in 2015 (p for trend< 0.0001). Conclusions Our study suggests that the incidence of PD has gradually decreased whereas, the incidence of DIP increased from 2012 to 2015. Further studies are warranted to examine possible causes of increased DIP incidence in order to develop management strategy for parkinsonism.

Sign in / Sign up

Export Citation Format

Share Document